Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy

Publication date

2016-03-28

Authors

Broekgaarden, MansISNI 0000000517904038
van Vught, R.W.M.ISNI 000000038938759X
Oliveira, SabrinaORCID 0000-0002-6011-2122ISNI 0000000392912295
Roovers, Rob C.ISNI 0000000387731721
van Bergen En Henegouwen, Paul MpORCID 0000-0001-6050-9042ISNI 0000000387765753
Pieters, Roland JORCID 0000-0003-4723-3584ISNI 0000000391858821
Van Gulik, T. M.
Breukink, E.J.ISNI 0000000392861563
Heger, MichalISNI 0000000390982433

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Photodynamic therapy for therapy-resistant cancers will greatly benefit from targeted delivery of tumor photosensitizing agents. In this study, a strategy for the site-specific conjugation of single domain antibodies onto liposomes containing the photosensitizer zinc phthalocyanine was developed and tested.

Keywords

Taverne, General Materials Science, SDG 3 - Good Health and Well-being

Citation

Broekgaarden, M, Van Vught, R, Oliveira, S, Roovers, R C, Van Bergen En Henegouwen, P M P, Pieters, R J, Van Gulik, T M, Breukink, E & Heger, M 2016, 'Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy', Nanoscale, vol. 8, no. 12, pp. 6490-6494. https://doi.org/10.1039/c6nr00014b